WHO signs MOU with International Generic and Biosimilar Medicines Association to promote access
WHO signs MOU with International Generic and Biosimilar Medicines Association to promote access Full access to medicines is hampered by a variety of factors. Two important barriers are high prices and regulatory issues such as long lag times in bringing medicines to market. To address these issues, Dr Tedros Adhanom…
WHAT IS PHARMA PATENTING: A JUDICIAL APPROACH
WHAT IS PHARMA PATENTING: A JUDICIAL APPROACH FROM {TAJ PHARMA INDIA} BRAND INFRINGEMENT ?Affluent societies are spending vast sums of money understandably on the search for new products and processes to alleviate suffering and to prolong life. In the process, drug manufactures have become a powerful industry. My idea of…